The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial (Q33848061)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial |
scientific article |
Statements
1 reference
The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial (English)
1 reference
Steven C Cramer
1 reference
Camille Fitzpatrick
1 reference
Michael Warren
1 reference
David Brown
1 reference
Laura Whitaker
1 reference
Karla J Ryckborst
1 reference
Lawrence Plon
1 reference
4 March 2010
1 reference
1 reference
41
1 reference
927-931
1 reference
Identifiers
1 reference
1 reference
1 reference